Clinical trial
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for…
NCT00310076 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00310076 |
|---|---|
| Title | Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer |
| Official title | Phase II Trial of Adjuvant Thalidomide Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis or Adenomucinosis From Colorectal/Appendiceal Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma of the Appendix, Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | thalidomide, surgery |
| Enrollment | 29 |
| Start date | Oct 1, 2002 |
| Primary completion | Jul 1, 2011 |
| Completion | Sep 1, 2012 |
| First posted | Apr 3, 2006 |
| Last update posted | Aug 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: